These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 19674787)

  • 1. A placental protective role for trophoblast-derived TNF-related apoptosis-inducing ligand (TRAIL).
    Bai X; Williams JL; Greenwood SL; Baker PN; Aplin JD; Crocker IP
    Placenta; 2009 Oct; 30(10):855-60. PubMed ID: 19674787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fetal-derived trophoblast use the apoptotic cytokine tumor necrosis factor-alpha-related apoptosis-inducing ligand to induce smooth muscle cell death.
    Keogh RJ; Harris LK; Freeman A; Baker PN; Aplin JD; Whitley GS; Cartwright JE
    Circ Res; 2007 Mar; 100(6):834-41. PubMed ID: 17322170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DR4 specific TRAIL variants are more efficacious than wild-type TRAIL in pancreatic cancer.
    Yu R; Albarenque SM; Cool RH; Quax WJ; Mohr A; Zwacka RM
    Cancer Biol Ther; 2014; 15(12):1658-66. PubMed ID: 25482930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. K+ channel inhibition modulates the biochemical and morphological differentiation of human placental cytotrophoblast cells in vitro.
    Williams JL; Fyfe GK; Sibley CP; Baker PN; Greenwood SL
    Am J Physiol Regul Integr Comp Physiol; 2008 Oct; 295(4):R1204-13. PubMed ID: 18703414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TNF-related apoptosis-inducing ligand (TRAIL) promotes trophoblast cell invasion via miR-146a-EGFR/CXCR4 axis: A novel mechanism for preeclampsia?
    Xiao C; Rui Y; Zhou S; Huang Y; Wei Y; Wang Z
    Placenta; 2020 Apr; 93():8-16. PubMed ID: 32090966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of proapoptotic anticancer therapeutic response in vivo based on cell death visualization and TRAIL death ligand-receptor interaction.
    Zhou L; Wang W; Dicker DT; Humphreys RC; El-Deiry WS
    Cancer Biol Ther; 2011 Aug; 12(4):335-48. PubMed ID: 21785270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of DDAH1, but not DDAH2, results in apoptosis of a human trophoblast cell line in response to TRAIL.
    Lumicisi BA; Cartwright JE; Leslie K; Wallace AE; Whitley GS
    Hum Reprod; 2015 Aug; 30(8):1813-9. PubMed ID: 26082478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of oxygen and tumor necrosis factor-alpha on the cellular kinetics of term placental villous explants in culture.
    Crocker IP; Tansinda DM; Jones CJ; Baker PN
    J Histochem Cytochem; 2004 Jun; 52(6):749-57. PubMed ID: 15150283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rosiglitazone promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP.
    Kim YH; Jung EM; Lee TJ; Kim SH; Choi YH; Park JW; Park JW; Choi KS; Kwon TK
    Free Radic Biol Med; 2008 Mar; 44(6):1055-68. PubMed ID: 18164688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importin β1 protein-mediated nuclear localization of death receptor 5 (DR5) limits DR5/tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-induced cell death of human tumor cells.
    Kojima Y; Nakayama M; Nishina T; Nakano H; Koyanagi M; Takeda K; Okumura K; Yagita H
    J Biol Chem; 2011 Dec; 286(50):43383-93. PubMed ID: 22020938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a novel anti-DR5 monoclonal antibody WD1 with the potential to induce tumor cell apoptosis.
    Wang J; Lin Z; Qiao CX; Lv M; Yu M; Xiao H; Wang Q; Wang L; Feng J; Shen B; Ma Y; Li Y
    Cell Mol Immunol; 2008 Feb; 5(1):55-60. PubMed ID: 18318995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of microcystin-LR on human placental villous trophoblast differentiation in vitro.
    Douglas GC; Thirkill TL; Kumar P; Loi M; Hilborn ED
    Environ Toxicol; 2016 Apr; 31(4):427-39. PubMed ID: 25346179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caudatin potentiates the anti-tumor effects of TRAIL against human breast cancer by upregulating DR5.
    Fei HR; Yuan C; Wang GL; Zhao Y; Li ZJ; Du X; Wang FZ
    Phytomedicine; 2019 Sep; 62():152950. PubMed ID: 31102888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations Enhancing Selectivity of Antitumor Cytokine TRAIL to DR5 Receptor Increase Its Cytotoxicity against Tumor Cells.
    Gasparian ME; Bychkov ML; Yagolovich AV; Dolgikh DA; Kirpichnikov MP
    Biochemistry (Mosc); 2015 Aug; 80(8):1080-91. PubMed ID: 26547077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and localization of estrogen receptor-alpha protein in normal and abnormal term placentae and stimulation of trophoblast differentiation by estradiol.
    Bukovsky A; Cekanova M; Caudle MR; Wimalasena J; Foster JS; Henley DC; Elder RF
    Reprod Biol Endocrinol; 2003 Feb; 1():13. PubMed ID: 12646062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR-mediated upregulation of DR5 and downregulation of cFLIP synergistically sensitize HeLa cells to TRAIL-mediated apoptosis.
    Poondla N; Chandrasekaran AP; Heese K; Kim KS; Ramakrishna S
    Biochem Biophys Res Commun; 2019 Apr; 512(1):60-65. PubMed ID: 30862357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of soluble tumor necrosis factor-related apoptosis-inducing ligand released by engineered adipose mesenchymal stromal cells on white blood cells.
    Casari G; Dall'Ora M; Melandri A; Masciale V; Chiavelli C; Prapa M; Neri G; Spano MC; Murgia A; D'Esposito A; Baschieri MC; Ceccherelli GB; Dominici M; Grisendi G
    Cytotherapy; 2023 Jun; 25(6):605-614. PubMed ID: 37012089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlation between sensitivity to TRAIL and expression level of DR5 on surface of tumor cells].
    Ma YF; Zhang J; Zhao YP; Yang DL; Chen YH
    Zhonghua Zhong Liu Za Zhi; 2004 Sep; 26(9):528-30. PubMed ID: 15555281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRAIL (Apo-2L) and TRAIL receptors in human placentas: implications for immune privilege.
    Phillips TA; Ni J; Pan G; Ruben SM; Wei YF; Pace JL; Hunt JS
    J Immunol; 1999 May; 162(10):6053-9. PubMed ID: 10229846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic ligands of death receptor 5 display a cell-selective agonistic effect at different oligomerization levels.
    Beyrath J; Chekkat N; Smulski CR; Lombardo CM; Lechner MC; Seguin C; Decossas M; Spanedda MV; Frisch B; Guichard G; Fournel S
    Oncotarget; 2016 Oct; 7(40):64942-64956. PubMed ID: 27409341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.